跳至主要内容
临床试验/NCT01794260
NCT01794260Unknown2 期

Efficacy and Safety of Topical Preparation of Essential Oil Extracted From Zingiber Cassumunar Rokb in Patients With Osteoarthritis

Mahidol University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
100
试验地点
1
主要终点
Change from baseline of The WOMAC (Western Ontario and McMaster Universities) index

研究概览

简要总结

The objectives of this study are to assess short term efficacy and safety of of topical preparation of essential oil extracted from ZINGIBER CASSUMUNAR ROXB in patients suffering from osteoarthritic pain

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis: osteoarthritis of the knee at least on side with standard radiologic method within 6 weeks (Kellgren-Lawrence radiographic grading scale at least 1)
  • Pain visual analog scale at rest at least 40 mm
  • No previous analgesic treatment or receiving stable dose of analgesic drugs at least 2 weeks. If previously treated with antidepressants, glucosamine, chondroitin or diacerein, dosage should be stable for at least 3 months.
  • Agree to attain non-pharmacologic treatment as prior to participate the study

排除标准

  • having an open wound or abnormal skin at site of application
  • having diagnose with other chronic arthritis such as rheumatoid arthritis
  • history of allergy to the extraction of Zingiber cassumunar Roxb
  • pregnancy or breastfeeding

研究组 & 干预措施

Plai cream

Experimental

Cream from Zingiber cassumunar Roxb. extract

干预措施: Cream from Zingiber cassumunar Roxb. extract (Drug)

Placebo cream

Placebo Comparator

Placebo cream

干预措施: Placebo cream (Drug)

结局指标

主要结局

Change from baseline of The WOMAC (Western Ontario and McMaster Universities) index

时间窗: week 8

次要结局

  • Change from baseline of Pain visual analog scale (PVAS)(week 8)
  • Change from baseline of Global assessment of disease status (GADS)(week 8)
  • Clinical global impression of change (CGIC)(Week 8)
  • Patient global impression of change (PGIC)(Week 8)
  • Adverse events(Week 8)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验